Amyloidosis: all 495 studies
Page 5 of 5. Open to participants first (135), then studies with results posted, then the rest; newest registration first within each.
- Biomarker for Transthyretin-Related Familial Amyloidotic Polyneuropathy (BioTRAP)WithdrawnNCT02713880
- Recurrent AA Amyloidosis After Renal TransplantationCompletedNCT02704065
- Florbetaben as an Amyloid Plaque Marker in Elderly Patients With Focal or Disseminated Superficial HemosiderosisWithdrawnNCT02664571Not applicable
- The Effect of an Antisense Oligonucleotide to Lower Transthyretin (TTR) Levels on the Progression of -Wild-type TTR Involving the HeartWithdrawnNCT02627820Phase 2
- Analysis of Oral Mucositis in Patient's Undergoing Melphalan Conditioning and Autologous Stem Cell TransplantWithdrawnNCT02589860
- Carpal Tunnel/Amyloidosis Blood Sample StudyCompletedNCT02587728
- Quality of Life (QOL) Registry for Patients With AL AmyloidosisCompletedNCT02574676
- 18F-Florbetaben PET Amyloid Imaging in Case of Intermediate CSF Biology for the Diagnosis of Alzheimer's Disease : a Pilot StudyCompletedNCT02556502Not applicable
- Minimal Residual Disease as a Possible Predictive Factor for Relapse in Patients With AL AmyloidosisCompletedNCT02555969
- Telomerase Activator and Retinal AmyloidCompletedNCT02530255Not applicable
- Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN StudyCompletedNCT02488720
- Bortezomib for Immunoglobulin Light Chain(AL) AmyloidosisCompletedNCT02485613
- Prospective Identification of Cardiac Amyloidosis by Cardiac Magnetic Resonance ImagingWithdrawnNCT02462213
- Depletion of Serum Amyloid P Component to Enhance the Immune Response to DNA VaccinationCompletedNCT02425241Phase 1/2
- Methods of Etiological Diagnosis of Cerebral Amyloid AngiopathyStatus unknownNCT02361411
- Capacity of Amylose Characterisation Compare by Immunohistochemistry and Proteomic AnalysisCompletedNCT02338427Not applicable
- A Study To Evaluate The Difference In iPad-Based Cognitive Video Game (Akili Interactive's Project: EVO) Performance In Amyloid-Positive Versus Amyloid-Negative Healthy Elderly VolunteersCompletedNCT02265718
- Prevalence and Post-surgical Outcomes of CARdiac Wild-type TransthyrEtin amyloidoSIs in Elderly Patients With Aortic steNosis Referred for Valvular Replacement.CompletedNCT02260466Not applicable
- Allo SCT in Amyloidosis Non-interventional StudyCompletedNCT02257905
- DISCOVERY: A Study Examining the Prevalence of TTR Mutations in Subjects Suspected of Having Cardiac AmyloidosisCompletedNCT02252653
- Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in Patients With AL AmyloidosisCompletedNCT02245867Phase 1
- Amyloïd Load in Elderly Population: Effect of Cognitive ReserveStatus unknownNCT02196116Not applicable
- Study of SOM0226 in Familial Amyloid PolyneuropathyCompletedNCT02191826Phase 1/2
- German Centre for Cardiovascular Research Cardiomyopathy RegisterStatus unknownNCT02187263
- Prevalence of Amyloidosis and Carpal TunnelWithdrawnNCT02152644
- Body Composition in Systemic AmyloidosisCompletedNCT02111538
- Studying the Effect of Dialysate Temperature on Toxin Removal and HypotensionCompletedNCT02064153Not applicable
- Nutritional Counseling in Systemic Immunoglobulin Light-chain AmyloidosisCompletedNCT02055534Not applicable
- A Study of the Safety, Tolerability and Pharmacokinetics of ALN-TTR02 in Japanese Healthy VolunteersCompletedNCT02053454Phase 1
- CNS and Plasma Amyloid-Beta Kinetics in Alzheimer's DiseaseCompletedNCT02021682
- Safety and Efficacy Study of Doxycycline/UrsoDeoxyCholicAcid on Disease Progression in ATTR AmyloidosisCompletedNCT02016365Phase 2
- A Trial for the Treatment of Cardiac AL-Amyloidosis With the Green Tea Compound Epigallocatechin-3-gallate (TAME-AL)CompletedNCT02015312Phase 2
- Bortezomib and Dexamethasone Followed by ASCT Compared With ASCT Alone in Treating Patients With AL AmyloidosisCompletedNCT01998503Phase 3
- Phase 2 Study to Evaluate ALN-TTRSC (Revusiran) in Patients With Transthyretin (TTR) Cardiac AmyloidosisCompletedNCT01981837Phase 2
- Superficial Siderosis in Patients With Suspected Cerebral Amyloid AngiopathyStatus unknownNCT01856699
- Radioimmunoimaging of Light Chain (AL) AmyloidosisCompletedNCT01815086Phase 1
- A Phase 1, Single- and Multi-Dose, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered ALN-TTRSC (Revusiran) in Healthy VolunteersCompletedNCT01814839Phase 1
- Pomalidomide With Melphalan and Dexamethasone for Untreated Systemic AL AmyloidosisTerminatedNCT01807286Phase 1
- A Safety Study of Carfilzomib in Patients With Previously-Treated Systemic Light Chain AmyloidosisCompletedNCT01789242Phase 1
- A Study to Evaluate the Safety of GSK2398852 When Co-administered With GSK2315698 in Patients With Systemic AmyloidosisCompletedNCT01777243Phase 1
- First-line Pomalidomide, Bortezomib, and Dexamethasone For AL Amyloidosis or LCDDTerminatedNCT01728259Phase 1
- Phase 1/2, Open Label, Dose Escalation Study of NEOD001 in Subjects With Light Chain (AL) AmyloidosisCompletedNCT01707264Phase 1/2
- Prevalence of Transthyretin Amyloidosis in Hypertrophic CardiomyopathyCompletedNCT01623245
- Long-term Outcomes of Patients With Primary Amyloidosis After Stem Cell TransplantationCompletedNCT01606280
- Trial to Evaluate Safety, Tolerability, and Parmacokinetics of ALN-TTR02 in Healthy Volunteer SubjectsCompletedNCT01559077Phase 1
- High Cut-off Hemodialysis in Patients With Advanced Cardiac AL Amyloidosis and End Stage Renal DiseaseWithdrawnNCT01531751Phase 2
- Risk-adapted Therapy for Primary Systemic (AL) AmyloidosisCompletedNCT01527032Phase 2
- Epigallocatechingallate (EGCG) in Cardiac AL AmyloidosisTerminatedNCT01511263Phase 2
- Pomalidomide and Dexamethasone (PDex) in AL AmyloidosisCompletedNCT01510613Phase 2
- The Effect of Diflunisal on Familial Transthyretin AmyloidosisCompletedNCT01432587
- Radioimmunoimaging of AL AmyloidosisCompletedNCT01409148Phase 1
- SAP Depleter Dose Assessment Study in PatientsCompletedNCT01406314Phase 1
- F-18-AV-45 Uptake, Spot Sign Presence and Cerebral Amyloid Angiopathy (CAA) in Primary Intracranial Hemorrhage (ICH)WithdrawnNCT01382849
- HIBA-Institutional Registry of AmyloidosisCompletedNCT01347047
- SAP Depleter Dose Escalation Study in Healthy VolunteersCompletedNCT01323985Phase 1
- A Trial for Systemic Light-chain (AL) AmyloidosisCompletedNCT01277016Phase 3
- Study of Bortezomib +HSCT in Primary Systemic Amyloidosis (AL)CompletedNCT01273844Not applicable
- Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA AmyloidosisCompletedNCT01215747Phase 3
- Lendexal in Patients With Primary Systemic Amyloidosis (AL) Newly DiagnosedCompletedNCT01194791Phase 2
- Safety, Efficacy and Pharmacokinetics of Doxycycline Plus Tauroursodeoxycholic Acid in Transthyretin AmyloidosisCompletedNCT01171859Phase 2
- Progression of Renal Amyloidosis of FMF and Relation to Serum SAA LevelStatus unknownNCT01168570
- Trial to Evaluate Safety and Tolerability of ALN-TTR01 in Transthyretin (TTR) AmyloidosisCompletedNCT01148953Phase 1
- B-Receptor Signaling in CardiomyopathyCompletedNCT01135849
- Influence of Age on Amyloid Load in Alzheimer's Disease and in Atypical Focal Cortical Alzheimer's DiseaseCompletedNCT01095744
- Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for CancerCompletedNCT01053494Not applicable
- Lenalidomide, Dexamethasone and Cyclophosphamide in Amyloidosis (AL)CompletedNCT00981708Phase 1/2
- Immune Mobilization of Autologous Peripheral Blood Stem Cells Using Interleukin-2 and GM-CSFCompletedNCT00952237Phase 1
- S0309, Repository: Blood/Bone Marrow From Pts. With Myeloma, WM, Amyloidosis, or MGUS.CompletedNCT00919139
- Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral TherapyCompletedNCT00890747Phase 1
- A Trial of Treatment With Lenalidomide-Melphalan-Dexamethasone in Patients With Primary (AL) AmyloidosisCompletedNCT00883623Phase 2
- Radioimmunoimaging of AL AmyloidosisCompletedNCT00807872Phase 1
- Lenalidomide in Combination With Melphalan and Dexamethasone in Newly-diagnosed Light-chain (AL)-AmyloidosisCompletedNCT00621400Phase 1/2
- Cyclophosphamide, Lenalidomide and Dexamethasone (CLD) for Previously Treated Patients With AL AmyloidosisCompletedNCT00607581Phase 2
- Characteristics of Patients With Amyloidosis & Heart Failure Being Evaluated for a Heart TransplantCompletedNCT00456040
- Q-Switched Nd:YAG in Macular AmyloidosisCompletedNCT00353392Phase 1
- Intensive Versus Conventional Treatment in Patients With Primary AmyloidosisCompletedNCT00344526Phase 3
- Phase II Trial of Enbrel in Patients With Primary Systemic AmyloidosisCompletedNCT00224393Phase 2
- Autologous Stem Cell Rescue for Primary AmyloidosisCompletedNCT00186407Phase 2
- Mixed Chimeric Transplantation for Primary AmyloidosisWithdrawnNCT00186095Not applicable
- Efficacy of CC-5013 (Revlimid or Lenalidomide) in Patients With Primary Systemic AmyloidosisCompletedNCT00166413Phase 2
- Melphalan, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed, Previously Untreated Primary Systemic AmyloidosisCompletedNCT00089167Phase 2
- Tandem Autologous Stem Cell Transplantation in Treating Patients With Primary Systemic (AL) AmyloidosisCompletedNCT00075621Phase 2
- Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell TransplantationTerminatedNCT00052884Phase 1
- Study of the Safety and Efficacy of NC-503 in Secondary (AA) AmyloidosisCompletedNCT00035334Phase 2/3
- Iododoxorubicin in Treating Patients With Primary Systemic AmyloidosisTerminatedNCT00030381Phase 1
- Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver DysfunctionCompletedNCT00025415Phase 1
- Study of High-Dose Melphalan and Autologous Stem Cell Transplantation in Patients With Primary Light Chain AmyloidosisCompletedNCT00017680Phase 2
- Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic MalignanciesCompletedNCT00014235Not applicable
- Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients Who Have Multiple Myeloma or Primary Systemic AmyloidosisCompletedNCT00007995Phase 2
- Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic CancerCompletedNCT00006251Phase 1/2
- Study of Systemic Amyloidosis Presentation and PrognosisStatus unknownNCT00004374
- 4'-Iodo-4'-Deoxydoxorubicin in Treating Patients With Primary Systemic AmyloidosisCompletedNCT00003853Phase 2
- High-Dose Melphalan Plus Peripheral Stem Cell Transplantation in Treating Patients With Primary Systemic AmyloidosisCompletedNCT00003353Phase 2
- S9628 Dexamethasone Plus Interferon Alfa in Treating Patients With Primary Systemic AmyloidosisCompletedNCT00002849Phase 2
- High-Dose Melphalan Followed by Peripheral Stem Cell Transplant in Treating Patients With AmyloidosisCompletedNCT00002810Phase 2